Randox's new and improved Tumour Marker Control features two new analytes, CA72-4 and thyroglobulin, and has received FDA clearance
The control now features eighteen tumour markers.
The tri-level control is liquid stable and has an open-vial stability of thirty days.
The pack size is still 9x2ml.
Randox assayed quality controls are supplied with target values and ranges for a wide range of instrumentation and methodologies.
